LATEST NEWS   EPF recorded a 30 per cent increase in total investment income to RM83.32 billion for 9M 2026 ended Sept 30, 2026, compared with RM63.99 billion in 9M 2025. | EPF’s 3Q 2026 total investment income rose three pct to RM25.82 bln from RM25.07 bln in 3Q 2025. | Targeted fuel subsidies closed avoidable leaks and gave the govt room to protect households while shouldering a much heavier fuel subsidy bill - Amir Hamzah | Govt studying methods to utilise former PLKN trainees as disaster volunteers - Ahmad Zahid | Ahmad Zahid proposes extension of PLKN training period to 90 or 180 days | 

SBC Medical Q3 Net Income Attributable Jumps 22 Pct

KUALA LUMPUR, Nov 16 (Bernama) -- SBC Medical Group Holdings Inc (SBC Medical) reported a 22 per cent year-on-year increase in net income attributable to the company to US$16 million for the third quarter (Q3) ended Sept 30, 2026, while revenue rose 35 per cent to US$59 million. (US$1 = RM4.08)

The company said revenue growth was driven by higher management services revenue, including the impact of service fee structure revisions announced in August, as well as the consolidation of Waqoo.

SBC Medical Chairman and Chief Executive Officer, Yoshiyuki Aikawa said the company's Medical Services Organization (MSO) revenue growth was supported by two key drivers: expanding its clinic network and increasing service fees per clinic.

Ad Banner
Ad Banner

“Our goal is not simply to add locations. We aim to raise productivity and profitability at the clinics we support while expanding the network efficiently,” he said in a statement.

Income from operations increased 66 per cent to US$26 million, with an operating margin of 45 per cent, while the net income margin was 27 per cent, down three percentage points from a year earlier.

Adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) rose 66 per cent to US$28 million, expanding its margin by nine percentage points to 47 per cent. Basic earnings per share increased 25 per cent to US$0.15.

Ad Banner
Ad Banner
Ad Banner

Its supported clinic network expanded by 36 locations year-on-year to 293 as of Sept 30, while patient visits over the trailing 12 months rose nine per cent to 7.06 million. Average spending per visit increased four per cent to US$290.

For the nine months ended Sept 30, revenue increased 13 per cent to US$151 million, while net income attributable to the company rose two per cent to US$38 million. Adjusted EBITDA grew 17 per cent to US$66 million.

Aikawa said the company would continue expanding its presence in Japan while pursuing international opportunities, including collaboration with OrangeTwist in the United States and expansion across ASEAN markets.

-- BERNAMA